2019.08.16
License Agreement Has Been Entered with Time Therapeutics, Inc.
License-Out
We executed an exclusive worldwide license agreement with Time Therapeutics, Inc. (Kyoto, Japan) for the development, production and sale of therapeutic and prophylactic agents for Alzheimer's disease under the patents on the use of related compounds licensed to us by Kyoto University.